schizophrenia Clinical Trials Database - Free Access to 206 Studies
Access comprehensive clinical trial information for schizophrenia through Pure Global AI's free database. This collection includes 206 clinical trials across multiple phases including N/A, Not Applicable, Early Phase 1. Currently, 47 trials are actively recruiting participants.
Research for schizophrenia is being conducted in Japan, China, Iran and 7+ other countries. Leading sponsors include Tehran University of Medical Sciences and National Center of Neurology and Psychiatry. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Lurasidone for the treatment of schizophrenia in paediatric patients
A clinical study using Evenamide (orally taken new drug with out masking its strenghth) to determine its safety, tolerability and efficacy in patients with treatment resistant schizophrenia, not befitting adequately from their current antipsychotic medication
Evaluation of the efficacy of resilience support provided by home nurses to schizophrenia living in the community
Untitled Trial
Persistence in patients with acute schizophrenia treated with brexpiprazole in the Japanese clinical practice: a retrospective 6-month follow-up study
A Non-Randomized Controlled Trial to Determine the Effect of Livestock on the Motivation and Anxiety of Patients with Chronic Schizophrenia
Association of serum ferritin levels with akathisia symptom in schizophrenia: a randomized controlled trial
Changes in the lives of people with schizophrenia as a result of using psychiatric day care
The Impact of Nursing Support Programs on Promoting Self-Understanding in Schizophrenic Patients in Adulthood
Development of tablet-based neurocognitive tests for patients with schizophrenia
Psychosocial effects of an individual occupational therapy using life review and collage book making for long-term hospitalized patients with schizophrenia.
Untitled Trial
A randomized single-blind trial of the therapeutic effects and safety of halved dose antipsychotics for treating relapse in patients with schizophrenia receiving high dose antipsychotic therapy
Aerobic exercise versus cognitive remediation versus a combination of both in patients with schizophrenia: a three-arm, randomized controlled pilot and feasibility study
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Pure Global AI provides free access to 206 clinical trials studying schizophrenia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Tehran University of Medical Sciences, National Center of Neurology and Psychiatry, The Second Xiangya Hospital of Central South University, among others.